期刊文献+

羟苯磺酸钙对青光眼患者视神经的保护作用 被引量:2

Clinical study on the optic nerve protection of calcium dobesilate in treating glaucoma
暂未订购
导出
摘要 目的:观察羟苯磺酸钙对眼压已经手术控制的青光眼患者的视神经保护作用。方法:选取本院2011-01/2012-02住院的原发性青光眼患者共78例89眼,按照数字表随机分为对照组和观察组,疗程6mo。观察治疗前后两组患者视力、视网膜平均感光度、眼压、视盘形态学的变化,以及评价疗效。结果:两组患者治疗前后视力、眼压、视盘形态学均无明显变化,差异无统计学意义。对照组患者治疗前后视网膜平均感光度无明显变化(14.75±5.17 vs 13.48±4.69),而治疗组患者经羟苯磺酸钙治疗,视网膜平均感光度明显改善(14.56±5.03 vs 18.9±5.77),差异有统计学意义(P<0.05),与对照组治疗后相比,差异亦有统计学意义(P<0.05)。对照组视网膜平均感光度改善率、稳定率、恶化率分别为10.3%,48.7%,41.0%;而观察组分别为64.1%,28.2%,7.7%,两组相比差异有统计学意义(P<0.05)。结论:羟苯磺酸钙能提高青光眼患者视网膜平均光敏感度,对眼压已控制的青光眼患者有视神经保护作用。 AIM: To observe the protective effect of calcium dobesilate on optic nerve of glaucoma patients whose intraocular pressure has been under control through operation. METHODS: A total of 78 inpatients ( 89 eyes ) with glaucoma in this hospital from January, 2011 to February, 2012 were enrolled.All patients were randomly divided into treatment group and control group with 6 months in a course.The visual acuity, visual field ( mean sensibility, MS), and intraocular pressure were measured at the experiment onset and 6 months later to evaluate the clinical effect. RESULTS: There were no statistically significant differences in the visual acuity, intraocular pressure between the two groups neither at the experiment onset nor after 6 months (P〉0.05).The mean sensibility (MS) of the treatment group was obviously improved (14.56 ± 5.03 vs 18.9 ±5.77, P〈0.05 ) with statistically significant differences before and after the treatment, while the MS remained unchanged in the control group (14.75±5.17 vs 13.48±4.69).There are statistically significant difference between the treatment group and the control group. Compared to the ratio of improvement, stability, and deterioration in the control group ( 10.3%, 48.7%, 41.0%) , the indexes were changed obviously in the treatment group (64.1%, 28.2%, 7.7%,P〈0.05) with statistically significant difference between the two groups.CONCLUSION:Calcium dobesilate can improve mean retinal sensitivity and protect the optic nerve in glaucoma patients whose intraocular pressure has been controlled.
出处 《国际眼科杂志》 CAS 2013年第12期2459-2461,共3页 International Eye Science
关键词 羟苯磺酸钙 青光眼 视神经 calcium dobesilate glaucoma optic nerve
  • 相关文献

参考文献13

  • 1葛坚.青光眼的研究进展与发展趋势[J].中华眼科杂志,2000,36(3):192-196. 被引量:160
  • 2董文娟.青光眼视神经保护临床分析[J].山西医药杂志(上半月),2012,41(12):1243-1244. 被引量:2
  • 3Vojnikovic B. Doxium ( calcium dobesilate ) reduces blood hyperviscosity and lowers elevated intraoeular pressure in patients with diabetic retinopathy and glaucoma. Ophthalmic Res 1991 ,23( 1 ) : 12-20.
  • 4赵家良,编译.眼科临床指南.北京:人民卫生出版社,2006:237-254.
  • 5刘文舟,罗向霞,段俊国,郑媛,路雪婧,张富文.灯盏花提取物对青光眼视神经保护作用的临床观察[J].中国实用眼科杂志,2011,29(8):794-797. 被引量:6
  • 6Turkoski BB. Glaucoma and glaucoma medications. Orthop Nurs 2012, 31(1) :37-41.
  • 7Pascale A, Drago F, Govoni S. Protecting the retinal neurons from glaucoma : lowering ocular pressure is not enough. Pharmacol Res 2012 , 66(1) :19-32.
  • 8Zhang K, Zhang L, Weinreb RN. Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma. Nat Rev Drug Discov 2012 , 11 ( 7 ) : 541-559.
  • 9Szabo ME, Haines D, Garay E ,et al. Antioxidant properties of calcium dobesilate in ischemic/reperfused diabetic rat retina. Eur J Pharmacol 2001 ,428(2) :277-286.
  • 10Rota R, Chiavaroli C, Garay RP, et al. Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats. Eur J Pharmacol 2004 ,495 (2-3) :217-224.

二级参考文献10

共引文献171

同被引文献25

  • 1王静波,陈美荣,李伯勤,林海青,于文洲.益阴明目合剂对高眼压大鼠视神经超微结构及血清NO、SOD的影响[J].山东中医杂志,2008,27(2):116-118. 被引量:2
  • 2郝晓丽.?&nbsp银杏叶片联合弥可保对青光眼术后视神经保护的疗效观察(J)河北医科大学学报. 2009 (12)
  • 3Shimazawa Masamitsu,Inokuchi Yuta,Okuno Takashi,Nakajima Yoshihiro,Sakaguchi Gaku,Kato Akira,Oku Hidehiro,Sugiyama Tetsuya,Kudo Takashi,Ikeda Tsunehiko,Takeda Masatoshi,Hara Hideaki.Reduced retinal function in amyloid precursor protein-over-expressing transgenic mice via attenuating glutamate-N-methyl-d-aspartate receptor signaling. Journal of Neurophysiology . 2008
  • 4Almasieh M,Zhou Y,Kelly M E,Casanova C,Di Polo A.Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptors. Cell death & disease . 2011
  • 5Aashish S. Morani,Subhash L. Bodhankar.??Early co-administration of vitamin E acetate and methylcobalamin improves thermal hyperalgesia and motor nerve conduction velocity following sciatic nerve crush injury in rats(J)Pharmacological Reports . 2010 (2)
  • 6Alessia Pascale,Filippo Drago,Stefano Govoni.??Protecting the retinal neurons from glaucoma: Lowering ocular pressure is not enough(J)Pharmacological Research . 2012 (1)
  • 7Edward V.Quadros.??Advances in the understanding of cobalamin assimilation and metabolism(J)British Journal of Haematology . 2009 (2)
  • 8王哲.益阴明目汤治疗中晚期青光眼的临床观察[J].中国中医药现代远程教育,2010,8(15):29-30. 被引量:3
  • 9李翔,郭红建,谢学军,王万杰.补肾活血中药联合甲钴胺片治疗眼压控制后青光眼的疗效观察[J].辽宁中医杂志,2010,37(9):1703-1706. 被引量:19
  • 10李玲丽,纪惠谦,梁敏,李宇航.弥可保治疗糖尿病缺血性视神经病变的效果[J].齐鲁医学杂志,2011,26(3):259-260. 被引量:3

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部